Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID) release_twlnvk3ginfo5bh4zml3bkprie

by Jim M Wild, Joanna C Porter, Philip L Molyneaux, Peter M George, Iain Stewart, Richard James Allen, Raminder Aul, John Kenneth Baillie, Shaney L Barratt, Paul Beirne, Stephen M Bianchi, John F Blaikley (+42 others)

Published in BMJ Open Respiratory Research by BMJ.

2021   Volume 8, Issue 1, e001049

Abstract

<jats:sec><jats:title>Introduction</jats:title>The COVID-19 pandemic has led to over 100 million cases worldwide. The UK has had over 4 million cases, 400 000 hospital admissions and 100 000 deaths. Many patients with COVID-19 suffer long-term symptoms, predominantly breathlessness and fatigue whether hospitalised or not. Early data suggest potentially severe long-term consequence of COVID-19 is development of long COVID-19-related interstitial lung disease (LC-ILD).</jats:sec><jats:sec><jats:title>Methods and analysis</jats:title>The UK Interstitial Lung Disease Consortium (UKILD) will undertake longitudinal observational studies of patients with suspected ILD following COVID-19. The primary objective is to determine ILD prevalence at 12 months following infection and whether clinically severe infection correlates with severity of ILD. Secondary objectives will determine the clinical, genetic, epigenetic and biochemical factors that determine the trajectory of recovery or progression of ILD. Data will be obtained through linkage to the Post-Hospitalisation COVID platform study and community studies. Additional substudies will conduct deep phenotyping. The Xenon MRI investigation of Alveolar dysfunction Substudy will conduct longitudinal xenon alveolar gas transfer and proton perfusion MRI. The POST COVID-19 interstitial lung DiseasE substudy will conduct clinically indicated bronchoalveolar lavage with matched whole blood sampling. Assessments include exploratory single cell RNA and lung microbiomics analysis, gene expression and epigenetic assessment.</jats:sec><jats:sec><jats:title>Ethics and dissemination</jats:title>All contributing studies have been granted appropriate ethical approvals. Results from this study will be disseminated through peer-reviewed journals.</jats:sec><jats:sec><jats:title>Conclusion</jats:title>This study will ensure the extent and consequences of LC-ILD are established and enable strategies to mitigate progression of LC-ILD.</jats:sec>
In application/xml+jats format

Archived Files and Locations

application/pdf  830.2 kB
file_yi43hfzh35euzaeuaenukart5u
bmjopenrespres.bmj.com (publisher)
web.archive.org (webarchive)
application/pdf  830.2 kB
file_5tpqd2zhinby7asiltswsr3kqy
discovery.ucl.ac.uk (web)
web.archive.org (webarchive)
application/pdf  830.2 kB
file_jmcgz3tmwjcrzpsjgtcepqon2a
bmjopenrespres.bmj.com (web)
web.archive.org (webarchive)
application/pdf  820.8 kB
file_vsrxoycttfe7rgy7c7rliawvr4
spiral.imperial.ac.uk (web)
web.archive.org (webarchive)
application/pdf  945.4 kB
file_dtdu4mao5nam3hra6e6a6rp6nm
discovery.dundee.ac.uk (web)
web.archive.org (webarchive)
application/pdf  967.8 kB
file_cvi7zrpf7zhlfaoos5zz5y6tqe
www.pure.ed.ac.uk (web)
web.archive.org (webarchive)
application/pdf  830.2 kB
file_lvouonxmljan7jf7hx4voeslrm
nottingham-repository.worktribe.com (web)
web.archive.org (webarchive)
application/pdf  830.3 kB
file_ggke6z5w7bfvth7abqqv5rcaqa
eprints.ncl.ac.uk (web)
web.archive.org (webarchive)
application/pdf  830.2 kB
file_oo3uxm4twzehvffhxiuz5ptbya
bmjopenrespres.bmj.com (web)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Year   2021
Language   en ?
Container Metadata
Open Access Publication
In DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:  2052-4439
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: e6136d0b-736d-404d-afeb-31341cc65947
API URL: JSON